|
The Surveillance, Epidemiology, and End Results Database Program on Endometrial Cancer in the Italian Population
RECRUITINGSponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Actively Recruiting
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Started2024-04-01
Est. completion2029-01-01
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07558889
Summary
The aim of this study is to lay the bases for an ambitious project that reports and records all the epidemiological-clinical information of the cases of endometrial carcinoma diagnosed and treated in the reference oncology centers involved on the national territory, to create a process of analysis of the data
Eligibility
Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria: * diagnosis of endometrial cancer (stage I-IV, G1-3, and special histotypes) * age \> 18 years * American Society of Anesthesiologists classification (ASA score) 1-3 * patients undergoing staging, cytoreduction or diagnostic surgery with acquisition of histological examination on which IHC and/or NGS studies have been performed for the molecular profile of the carcinoma * Signed informed consent Exclusion Criteria: * patients with missing information * patients not treated in the participating centers for which only partial and fragmented information will be available * molecular profile not known and\\or not recoverable and retrospectively analysable
Conditions3
CancerEndometrium CancerGynecologic Cancer
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Started2024-04-01
Est. completion2029-01-01
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07558889